Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Reduced Dose Alemtuzumab for Severe Kidney Transplant Rejection

NCT06100965 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06100965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06100965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Reduced Dose Alemtuzumab for Severe Kidney Transplant Rejection
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Unknown status
Start date
December 1, 2023
Completion date
July 1, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant rejection